AUTHOR=Bremner Fion 

TITLE=Apraclonidine Is Better Than Cocaine for Detection of Horner Syndrome

JOURNAL=Frontiers in Neurology

VOLUME=Volume 10 - 2019

YEAR=2019

URL=https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2019.00055

DOI=10.3389/fneur.2019.00055

ISSN=1664-2295

ABSTRACT=Background:  In suspected cases of Horner syndrome pharmacological confirmation is often required before embarking on further investigations.  The two drugs commercially available for this purpose are cocaine (2-10%) and apraclonidine (0.5-1.0%).
Aims:  To evaluate and compare the effects of both drugs in normal eyes and eyes with Horner syndrome
Methods:  This is a retrospective study looking at the outcome of 660 consecutive pharmacological tests with these two drugs in one tertiary referral centre over 14 years.  Eyes were categorised as ‘normal’ or ‘Horner syndrome’ based on non-pharmacological criteria (pupillometric and clinical evidence). Pupil diameters in the dark and in bright light were measured by pupillometry before and 40 minutes after administration of the test drug (either 4% cocaine or 0.5% apraclonidine. 
Results:  Cocaine dilated the normal pupil (measured in bright light: mean +2.1mm, range -0.4 to +3.9mm; 95% lower limit +0.5mm); the extent of this response was not significantly affected by patient age or pupil size, but was 50% less in brown eyes compared with blue or green eyes, and 20% less if the measurements were made in the dark. In eyes with Horner syndrome cocaine had significantly less mydriatic effect (mean +0.7mm, range -0.7 to +2.9mm).  Apraclonidine constricted the normal pupil (measured in the dark: mean -0.4mm, range -1.3 to +0.8mm; 95% upper limit +0.1mm); eye colour made no difference but the response was significantly greater in younger patients and larger pupils and significantly less if measured in bright lighting conditions. In eyes with Horner syndrome apraclonidine dilated the pupil (mean +0.6, range -0.4 to +2.3mm). Applying the 95% limits identified from my normative data, I estimate the sensitivity of each drug test for detection of Horner syndrome at 40% for cocaine (criterion: mydriasis < 0.5mm in darkness) compared with 93% for apraclonidine (criterion: mydriasis ≥ 0.1mm in darkness).
Conclusions:  Apraclonidine is a more sensitive test than cocaine for detection of Horner syndrome, and should be adopted as the new gold standard in routine clinical practice. However caution is needed when using this drug within hours of a suspected sympathetic lesion, or in infants under 1 year of age.